help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Janovick, J. A.
Right arrow Articles by Conn, P. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Janovick, J. A.
Right arrow Articles by Conn, P. M.

Endocrinology, Vol 136, 202-208, Copyright © 1995 by Endocrine Society

ARTICLES

GH3 cells transfected with gonadotropin-releasing hormone (GnRH) receptor complementary deoxyribonucleic acid release secretogranin-II through a constitutive pathway after GnRH analog-regulated synthesis: evidence that secretory proteins do not contain a sequence that obligates processing through a secretory granule or by regulated secretion

JA Janovick, L Jennes and PM Conn
Oregon Regional Primate Research Center, Beaverton 97006.

GGH3 cells (lactotropic GH3 cells transfected with rat GnRH receptor complementary DNA) respond to GnRH agonists with time- and dose- dependent release of secretogranin-II (SII), a molecule believed to be a marker of the regulated pathway of release and a component of secretory granules. Release requires both protein and RNA synthesis and is also stimulated by analogs of the cyclic nucleotides. Release, as such, appears to be determined by the availability of SII, because this process is constitutive once the molecule is synthesized, and intracellular levels are at the same steady state whether the receptor is occupied by an agonist or an antagonist or is unoccupied. This synthetic requirement is consistent with the lag in time from stimulation to release and the inhibitory actions of either cycloheximide or actinomycin-D on secretion as well as the morphologic observation that storage granules (i.e. secretory granules) are absent in these cells. SII, accordingly, can be released constitutively and does not require processing through the so-called regulated secretory pathway. These observations suggest, in addition, that proteins associated with release through regulated pathways do not have "sorting" domains that preclude release via constitutive routes or require processing through secretory granules.


This article has been cited by other articles:


Home page
 J. Biol. Chem.Home page
U. B. Kaiser, E. Sabbagh, M. T. Chen, W. W. Chin, and B. D. Saunders
Sp1 Binds to the Rat Luteinizing Hormone beta  (LHbeta ) Gene Promoter and Mediates Gonadotropin-releasing Hormone-stimulated Expression of the LHbeta Subunit Gene
J. Biol. Chem., May 22, 1998; 273(21): 12943 - 12951.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
U. B. Kaiser, E. Sabbagh, B. D. Saunders, and W. W. Chin
Identification of cis-Acting Deoxyribonucleic Acid Elements That Mediate Gonadotropin-Releasing Hormone Stimulation of the Rat Luteinizing Hormone {beta}-Subunit Gene
Endocrinology, May 1, 1998; 139(5): 2443 - 2451.
[Abstract] [Full Text] [PDF]

Home page
 Endocr. Rev.Home page
U. B. Kaiser, P. M. Conn, and W. W. Chin
Studies of Gonadotropin-Releasing Hormone (GnRH) Action Using GnRH Receptor-Expressing Pituitary Cell Lines
Endocr. Rev., February 1, 1997; 18(1): 46 - 70.
[Abstract] [Full Text]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1995 by The Endocrine Society